SPECIAL EU LOW PRICE DEVELOPING COUNTRY MEDICINE SCHEME LOSES SALES
January 1st, 2013
THE EUROPEAN Commission has reported a dramatic decrease in the number of medicines being sold at low prices to poorer countries under a special European Union (EU) scheme. It says that total sales of these “registered tiered priced medicines” for diseases such as AIDS/HIV and tuberculosis have significantly and steadily decreased over the last six years: “The total sales of 2011 represent just 3% of the total sales of 2005.” This is mainly because customers in these countries are purchasing anti-retrovirals (ARVs) from other producers and “in ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.